transient elastography (Echosens North America)
86
Structured Review
Echosens North America
transient elastography
Transient Elastography, supplied by Echosens North America, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elastography/fibroscan/pmc09069630-115-18-21
Average 86 stars, based on 1 article reviews
Transient Elastography, supplied by Echosens North America, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elastography/fibroscan/pmc09069630-115-18-21
Average 86 stars, based on 1 article reviews
transient elastography - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Shear:Article Title: Non-invasive ultrasound assessment of chronic liver disease: current position and future directions for a "one-stop" liver ultrasound approach. Article Snippet: .. Numerous studies have now established the accuracy of the ultrasound-based shear wave elastography techniques, with evidence at least demonstrating non-inferiority to the transient other:Article Title: Dietary index for gut microbiota and risk of hypertension: the mediating role of HOMA-IR in a five-year prospective cohort study in Iranian adults. Article Snippet: Hepatic steatosis was evaluated by transient Article Title: Fibrosis progression rate and comparison of paired liver biopsy versus non-invasive tests as surrogate endpoints for clinical trials in MetALD and ALD. Article Snippet: TE was conducted using vibrationcontrolled transient Article Title: Alcohol Intake, Cardiometabolic Risk, Fibrosis, and Gut Microbiota in Steatotic Liver Disease: A Population-Based Health Checkup Study. Article Snippet: Liver stiffness (LSM) and hepatic fat content, determined via the controlled attenuation parameter (CAP), were measured by transient Biomarker Discovery:Article Title: Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradication. Article Snippet: .. Pretherapy metabolic dysfunction-associated steatotic liver disease (MASLD) was defined by hepatic steatosis, determined either via controlled attenuation parameter (CAP) ≥238 dB/m by vibration-controlled transient Clinical Proteomics:Article Title: Simple model stratifies liver cancer risk in non-cirrhotic chronic hepatitis C patients after viral eradication. Article Snippet: .. Pretherapy metabolic dysfunction-associated steatotic liver disease (MASLD) was defined by hepatic steatosis, determined either via controlled attenuation parameter (CAP) ≥238 dB/m by vibration-controlled transient |